Deliver (Q3989474): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item: Fix Beneficiary from Netherlands) |
||
Property / beneficiary name (string) | |||
Caelus Pharmaceuticals B.V. | |||
Property / beneficiary name (string): Caelus Pharmaceuticals B.V. / rank | |||
Normal rank | |||
Property / beneficiary | |||
Property / beneficiary: Q3987337 / rank | |||
Normal rank |
Revision as of 09:42, 16 December 2021
Project Q3989474 in Netherlands
Language | Label | Description | Also known as |
---|---|---|---|
English | Deliver |
Project Q3989474 in Netherlands |
Statements
78,331.0 Euro
0 references
391,654.0 Euro
0 references
20.0 percent
0 references
1 January 2019
0 references
31 December 2021
0 references
Caelus Pharmaceuticals B.V.
0 references
1105 BP
0 references
Het microbioom, de samenstelling van de micro-organismes in de darm, speelt een centrale rol in het behoud van de gezondheid. Een verstoord microbiotisch evenwicht is geassocieerd met verschillende ziektes zoals obesitas, metabool syndroom, type 2... (Dutch)
0 references
The microbiome, the composition of the micro-organisms in the intestine, plays a central role in maintaining health. An impaired microbiotic balance is associated with various diseases such as obesity, metabolic syndrome, type 2... (English)
15 December 2021
0 references
Le microbiome, la composition des micro-organismes dans l’intestin, joue un rôle central dans le maintien de la santé. Un équilibre microbiotique altéré est associé à diverses maladies telles que l’obésité, le syndrome métabolique, le type 2... (French)
15 December 2021
0 references
Das Mikrobiom, die Zusammensetzung der Mikroorganismen im Darm, spielt eine zentrale Rolle bei der Erhaltung der Gesundheit. Ein beeinträchtigtes mikrobiotisches Gleichgewicht ist mit verschiedenen Krankheiten wie Fettleibigkeit, Stoffwechselsyndrom, Typ 2... (German)
15 December 2021
0 references
Identifiers
OP-2014-2023-West-KVW-00211
0 references